SCLC 2026: 40% Longer Survival + $31K/Mo Costs – New Treatment Breakthrough Guide
SCLC patients now have 40% longer survival with tarlatamab therapy approved in 2024. Learn about $31K monthly treatment costs, insurance coverage, and financial assistance programs for 2026.